Epidemiology and outcomes of hospitalized adults with respiratory syncytial virus: A 6‐year retrospective study
Influenza and Other Respiratory Viruses2019Vol. 13(4), pp. 331–338
Citations Over TimeTop 12% of 2019 papers
Abstract
Respiratory syncytial virus in hospitalized adults is associated with significant morbidity and mortality with 26.9% requiring ICU level care. Antibiotics are commonly prescribed to patients with documented RSV, and antibiotics are frequently continued after diagnosis. Novel antiviral therapies are needed for RSV to improve outcomes and potentially improve antibiotic stewardship in patients without a bacterial infection.
Related Papers
- → OVERVIEW OF BRONCHIOLITIS(1993)82 cited
- → Controversies in the management of children with bronchiolitis(2004)17 cited
- → Bronchiolitis Admissions in a Lebanese Tertiary Medical Center: A 10 Years' Experience(2019)6 cited
- → Total immunoglobulin E in infant bronchiolitis and risk of developing asthma(2022)2 cited
- → Marked Variability Observed in Inpatient Management of Bronchiolitis in a tertiarycenter. Can we do better?(2020)